[Federal Register Volume 77, Number 21 (Wednesday, February 1, 2012)]
[Notices]
[Page 5026]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-2140]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following federal committee meeting.
Times and Dates:
8 a.m.--5:30 p.m., February 22, 2012
8 a.m.--1 p.m., February 23, 2012
Place: CDC, Tom Harkin Global Communications Center, 1600
Clifton Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate dose, administration interval, age groups and
contraindications applicable to the vaccines. Further, under
provisions of the Affordable Care Act, at section 2713 of the Public
Health Service Act, immunization recommendations of the ACIP that
have been adopted by the Director of the Centers for Disease Control
and Prevention must be covered by applicable health plans.
Matters To Be Discussed: The agenda will include discussions on:
meningococcal vaccine, hepatitis B vaccine, tetanus, diphtheria, and
acellular pertussis (Tdap) vaccine, influenza, vaccine supply, 13-
valent pneumococcal conjugate vaccine, and measles-mumps-rubella
(MMR) vaccine. A VFC vote is scheduled for meningococcal vaccines.
Recommendation votes are scheduled for meningococcal vaccines and
for Tdap vaccine. Time will be available for public comment.
Agenda items are subject to change as priorities dictate.
The Meeting is webcast live via the World Wide Web; for
instructions and more information on ACIP please visit the ACIP Web
site: http://www.cdc.gov/vaccines/recs/acip/.
Contact Person for More Information: Stephanie B. Thomas,
National Center for Immunization and Respiratory Diseases, CDC, 1600
Clifton Road, NE., MS-A27, Atlanta, Georgia 30333, telephone 404
639-8836; Email [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: January 25, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-2140 Filed 1-31-12; 8:45 am]
BILLING CODE 4160-18-P